These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 6739839)

  • 1. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. VII. Phonoangiographic study].
    Szmatłoch E; Olejak B; Gregorczyk J; Pieczul-Mróz J; Brzeźniak R; Ansilewski K; Jagła A; Kutrzeba J
    Przegl Lek; 1984; 41(2):213-6. PubMed ID: 6739839
    [No Abstract]   [Full Text] [Related]  

  • 2. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. VI. Evaluation of arterial elasticity based on the physical analysis of blood circulation].
    Szmatłoch E; Olejak B; Gregorczyk J; Pieczul-Mróz J; Jagła A; Kutrzeba J; Cwajda H
    Przegl Lek; 1983; 40(11):803-6. PubMed ID: 6669733
    [No Abstract]   [Full Text] [Related]  

  • 3. [Musculoskeletal symptoms in patients with primary hyperlipoproteinemia. A prelimary study].
    Brekke SE; Kogstad OA
    Tidsskr Nor Laegeforen; 1979 Oct; 99(29):1444-6. PubMed ID: 516016
    [No Abstract]   [Full Text] [Related]  

  • 4. [Hyperlipoprotein phenotypes as risk factors in ischemic cardiopathy. II. Clinical aspects].
    Walter-Rosianu A
    Rev Pediatr Obstet Ginecol Pediatr; 1984; 33(2):145-60. PubMed ID: 6429817
    [No Abstract]   [Full Text] [Related]  

  • 5. [Hyperlipoproteinemia, HDL-cholesterol and arteriosclerosis indices].
    Herrmann W; Reuter W
    Z Gesamte Inn Med; 1982 Dec; 37(24):830-3. PubMed ID: 6963524
    [No Abstract]   [Full Text] [Related]  

  • 6. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis].
    Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R
    Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Early and late results of coronary artery bypass in patients with hyperlipoproteinemia.
    Hanson EC; Levine FH; Adzick NS; Lees RS; Daggett WM; Austen WG; Buckley MJ
    J Thorac Cardiovasc Surg; 1980 Mar; 79(3):372-80. PubMed ID: 6965512
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipoprotein lipase activity of ischemic heart disease patients with different types of hyperlipoproteinemia on the basis of fat loading].
    Nikul'cheva NG; Soliternova IB; Krivoruchenko IV
    Vopr Med Khim; 1980; 26(6):808-13. PubMed ID: 7456412
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Primary hyperlipoproteinemia in its clinical and laboratory aspects. IV. Blood coagulation and fibrinolysis indicators].
    Borodin M; Jurek D; Gregorczyk J; Pieczul-Mróz J; Cwajda H
    Przegl Lek; 1983; 40(10):727-32. PubMed ID: 6665208
    [No Abstract]   [Full Text] [Related]  

  • 10. Non-invasive evaluation of iliac and carotid atherosclerosis in familial hypercholesterolemia.
    Rubba P; De Simone B; Postiglione A; Cortese C; Gnasso A; Mancini M
    Beitr Infusionsther; 1988; 23():33-8. PubMed ID: 2484780
    [No Abstract]   [Full Text] [Related]  

  • 11. [Localization of vessel lesions in arteriosclerosis and blood lipid composition].
    Lipovetskiĭ BM; Vinogradova TV
    Ter Arkh; 2002; 74(2):55-7. PubMed ID: 11899828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyperlipidemia with infantile hemiplegia.
    Sheth SS; Karande SC; Lahiri K; Jain MK; Shah MD
    Indian Pediatr; 1990 Oct; 27(10):1111-4. PubMed ID: 2090603
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cholesterol and triglyceride plasma levels in patients with primary hyperlipoproteinemia. Decline after short-term i.v. glucagon administration].
    Andĕl M; Brodan V; Kucerová L; Grafnetter D; Kuhn E; Veselková A
    Cas Lek Cesk; 1980 May; 119(22):616-21. PubMed ID: 7427980
    [No Abstract]   [Full Text] [Related]  

  • 14. [Incidence of dyslipoproteinemias in familial epilepsy].
    Havlová M; Sobra J
    Cesk Pediatr; 1987 Dec; 42(12):707-11. PubMed ID: 3442851
    [No Abstract]   [Full Text] [Related]  

  • 15. Behaviour of uricemia in hyperlipoproteinemic subjects.
    Zdrenghea D; Marta D; Constantinescu M; Cucuianu M
    Med Interne; 1980; 18(4):385-90. PubMed ID: 7455583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Genetic aspects of arteriosclerosis].
    Maciołowski M
    Przegl Lek; 1983; 40(10):743-7. PubMed ID: 6364256
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations.
    Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP
    Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyperlipoproteinemias as risk factors for ischemic cardiopathy: new diagnostic possibilities].
    Gaddi A; Scaramuzzino G; Benassi MS; Aluigi L; Ceredi C; Albertazzi I; Suffritti G; Descovich GC
    Boll Soc Ital Cardiol; 1978; 23(9):1537-44. PubMed ID: 553627
    [No Abstract]   [Full Text] [Related]  

  • 19. [Incidence and characteristics of dyslipoproteinemia in men with ischemic heart disease detected in an epidemiologic study].
    Lipovetskiĭ BM; Nikul'cheva NG; Shestov DB; Plavinskaia SI
    Kardiologiia; 1982 Aug; 22(8):23-6. PubMed ID: 7132036
    [No Abstract]   [Full Text] [Related]  

  • 20. [Primary hyperlipoproteinemia from its clinical and laboratory aspects. V. Evaluation of circulatory hemodynamics based on the measurements of systolic time intervals and the physical analysis of blood circulation].
    Olejak B; Szmatłoch E; Brzeźniak R; Gregorczyk J; Pieczul-Mróz J; Jankowska E; Jagła A
    Przegl Lek; 1983; 40(11):797-801. PubMed ID: 6669732
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.